<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_HLY2882 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEmmc1 pptx ?><?FILEmmc2 xlsx ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Heliyon</journal-id><journal-id journal-id-type="iso-abbrev">Heliyon</journal-id><journal-title-group><journal-title>Heliyon</journal-title></journal-title-group><issn pub-type="epub">2405-8440</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6881638</article-id><article-id pub-id-type="publisher-id">S2405-8440(19)36541-7</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2019.e02882</article-id><article-id pub-id-type="publisher-id">e02882</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Tajima</surname><given-names>Shigeru</given-names></name><email>stajima@nih.go.jp</email><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Shibasaki</surname><given-names>Ken-ichi</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Taniguchi</surname><given-names>Satoshi</given-names></name></contrib><contrib contrib-type="author" id="au4"><name><surname>Nakayama</surname><given-names>Eri</given-names></name></contrib><contrib contrib-type="author" id="au5"><name><surname>Maeki</surname><given-names>Takahiro</given-names></name></contrib><contrib contrib-type="author" id="au6"><name><surname>Lim</surname><given-names>Chang-Kweng</given-names></name></contrib><contrib contrib-type="author" id="au7"><name><surname>Saijo</surname><given-names>Masayuki</given-names></name></contrib></contrib-group><aff id="aff1">Department of Virology 1, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo, 162-8640, Japan</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>stajima@nih.go.jp</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>23</day><month>11</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>11</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2019</year></pub-date><volume>5</volume><issue>11</issue><elocation-id>e02882</elocation-id><history><date date-type="received"><day>10</day><month>9</month><year>2019</year></date><date date-type="rev-recd"><day>1</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s)</copyright-statement><copyright-year>2019</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>We previously showed that the Japanese encephalitis virus (JEV) genotype V (GV) strain Muar exhibits significantly higher virulence in mice than the genotype I (GI) JEV strain Mie/41/2002. In this study, we attempted to identify the region responsible for the increased virulence of GV JEV using recombinant intertypic and single mutant JEVs. Intertypic viruses containing the GV E region in the Mie/41/2002 backbone showed increased pathogenicity in mice. The amino acid at position 123 in the E protein (E123) of the Mie/41/2002 and GV JEVs was serine and histidine, respectively. A serine-to-histidine substitution at E123 of the Mie/41/2002 increased its virulence. However, histidine-to-serine changes at E123 in the intertypic mutants with the GV E region remained highly virulent. GV Muar prM-bearing mutants were also highly pathogenic in mice. Our results suggest that the E and prM proteins of GV JEV are responsible for the highly virulent characteristics of GV JEV.</p></abstract><abstract abstract-type="teaser" id="abs0015"><p>Genetics; Microbiology; Virology; Japanese encephalitis virus; Genotype V; E protein; prM protein; Pathogenicity; Reverse genetics; Infectious cDNA clone</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Genetics</kwd><kwd>Microbiology</kwd><kwd>Virology</kwd><kwd>Japanese encephalitis virus</kwd><kwd>Genotype V</kwd><kwd>E protein</kwd><kwd>prM protein</kwd><kwd>Pathogenicity</kwd><kwd>Reverse genetics</kwd><kwd>Infectious cDNA clone</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Japanese encephalitis (JE) is a severe central nervous system disease caused by infection with the Japanese encephalitis virus (JEV). JE represents a significant public health problem in Asia, with an estimated 68,000 cases of JE per year resulting in 15,000 fatalities, mostly in children (<xref rid="bib37" ref-type="bibr">Tsai, 2000</xref>) (<xref rid="bib7" ref-type="bibr">Erlanger et&#x000a0;al., 2009</xref>) (<xref rid="bib2" ref-type="bibr">Campbell et&#x000a0;al., 2011</xref>). JEV belongs to the genus <italic>Flavivirus</italic> in the family <italic>Flaviviridae</italic> and is amplified in a bird and pig-mosquito transmission cycle (<xref rid="bib27" ref-type="bibr">Pierson and Diamond, 2013</xref>). The infected mosquitoes, mainly <italic>Culex</italic> sp., transmit JEV to humans.</p><p id="p0015">JEV has a single-stranded, positive-sense RNA genome. The JEV genome encodes three structural proteins (C, prM, and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) from one open reading frame, and it also has non-coding regions (NCRs) at its 5&#x02032;- and 3&#x02032;-terminal ends. JEV strains are classified into five genotypes (GI, GII, GIII, GIV, and GV) on the basis of genomic RNA homology (<xref rid="bib38" ref-type="bibr">Uchil and Satchidanandam, 2001</xref>) (<xref rid="bib31" ref-type="bibr">Solomon et&#x000a0;al., 2003</xref>). The GIII strains were the most widely distributed in JE-endemic areas until the 1990s. However, in most of these regions the prevalent genotype has since transitioned from GIII to GI (<xref rid="bib9" ref-type="bibr">Gao et&#x000a0;al., 2013</xref>) (<xref rid="bib29" ref-type="bibr">Schuh et&#x000a0;al., 2014</xref>). The first GV JEV (Muar strain) was isolated from a patient with encephalitis in Malaysia in 1952; however, no other GV JEV isolates were subsequently found in over 50 years (<xref rid="bib31" ref-type="bibr">Solomon et&#x000a0;al., 2003</xref>). In 2009, GV JEV was identified in a <italic>Culex</italic> mosquito pool in China, and the infectious virus (XZ0934 strain) was isolated (<xref rid="bib16" ref-type="bibr">Li et&#x000a0;al., 2011</xref>). GV JEV was also detected in mosquitoes in Korea in 2010 (<xref rid="bib36" ref-type="bibr">Takhampunya et&#x000a0;al., 2011</xref>). Moreover, all the JEV genomes detected in mosquito pools collected in Korea after 2012 originated from GV JEV (<xref rid="bib12" ref-type="bibr">Kim et&#x000a0;al., 2015</xref>) (<xref rid="bib1" ref-type="bibr">Bae et&#x000a0;al., 2018</xref>). In Korea GI, GIII, and GV JEV have been endemic in recent years, and it is critical to monitor the dynamics of circulating JEV strains in other JE-endemic areas.</p><p id="p0020">All live attenuated and inactivated JE vaccines that are currently available are derived from GIII strains. Previous reports showed that these JE vaccines might have a reduced ability to induce neutralizing antibodies against GV JEV than against other genotypes (<xref rid="bib3" ref-type="bibr">Cao et&#x000a0;al., 2016</xref>; <xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). Furthermore, another report revealed that IgG antibodies raised against GV JEV XZ0934 had poor neutralizing ability against GIII JEV (<xref rid="bib6" ref-type="bibr">de Wispelaere et&#x000a0;al., 2015</xref>). These findings raise the possibility that GV JEV is distinct from other JEV genotypes in antigenicity, and the current GIII-derived JE vaccines might not provide adequate levels of protection against GV JEV. The low identity in the amino acid sequences between GV and GIII JEV may be involved in the weak efficacy of the GIII-derived vaccines against GV JEV (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>), although more detailed studies are needed to evaluate the efficacy of the current JE vaccines against GV JEV.</p><p id="p0025">Understanding the characteristics of GV JEV is essential for determining the response to emerging GV JEVs. However, the characteristics of GV JEV remain to be fully elucidated, as only two GV JEV strains have been isolated to date and only limited studies have been conducted on these strains. We previously showed that GV JEV Muar has unique features in <italic>in vitro</italic> growth and exhibits increased pathogenicity in mice. The growth ability of Muar in cultured mammalian cells was clearly reduced compared to that of GI JEV Mie/41/2002, and conversely, the neuroinvasiveness of Muar was significantly higher than that of Mie/41/2002 (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). A French group also showed that a recombinant GV JEV of the XZ0934 strain exhibited a higher virulence in mice than recombinant GIII JEV (<xref rid="bib6" ref-type="bibr">de Wispelaere et&#x000a0;al., 2015</xref>). Moreover, the same group also demonstrated that the structural protein region (C-prM-E) of XZ0934 plays a critical role in the increased pathogenicity of XZ0934 (<xref rid="bib6" ref-type="bibr">de Wispelaere et&#x000a0;al., 2015</xref>).</p><p id="p0030">In the present study, we attempted to determine the region in GV JEV responsible for its higher pathogenicity in mice. For this purpose, recombinant intertypic chimeric and missense mutant JEVs in the backbone of the GI JEV Mie/41/2002 strain were produced using a reverse genetics system that we previously established, and these were then used for virulence analysis.</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Ethics statement</title><p id="p0035">Experiments on mice were performed in accordance with the Guidelines for Animal Experiments Performed at the National Institute of Infectious Diseases (NIID), under approval (no.117141, 118011, 118100, 118151, and 119021) from the Animal Welfare and Animal Care Committee of the NIID, Japan. All efforts were made to minimize pain and distress. The mice infected with JEV were observed daily for adverse reactions and signs of disease. For collection of organ samples, mice were euthanized using isoflurane.</p></sec><sec id="sec2.2"><label>2.2</label><title>Cell culture</title><p id="p0040">All the cell lines used in this study are maintained at our department. African green monkey kidney Vero cells (strain 9013) and human neuroblastoma IMR-32 cells were cultured at 37 &#x000b0;C in 5% CO<sub>2</sub> in Eagle's Minimal Essential Medium (MEM) (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Sigma-Aldrich) and 100 U/mL penicillin-streptomycin. Mouse neuroblastoma N18 cells were cultured at 37 &#x000b0;C in 5% CO<sub>2</sub> in Dulbecco's modified Eagle's medium (DMEM) (Sigma-Aldrich) supplemented with 10% FBS and 100 U/mL penicillin-streptomycin (Thermo Fisher Scientific, Waltham, MA).</p></sec><sec id="sec2.3"><label>2.3</label><title>Viruses</title><p id="p0045">All the viruses used in this study are maintained at our department. GI JEV strain Mie/41/2002 (GenBank accession no. <ext-link ext-link-type="uri" xlink:href="ncbi-n:AB241119" id="intref0010">AB241119</ext-link>), which was isolated from pig serum in Japan in 2002 (<xref rid="bib23" ref-type="bibr">Nerome et&#x000a0;al., 2007</xref>; <xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>), and GV JEV strain Muar (GenBank accession no. HM596272), which was isolated from a patient with encephalitis in Malaysia in 1952, were used (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). The working virus stocks were prepared by amplification in Vero cells.</p></sec><sec id="sec2.4"><label>2.4</label><title>Recombinant viruses</title><p id="p0050">Fourteen JEV molecular clones of intertypic and missense mutant viruses, namely rJEV-5NCME<sup>Muar</sup>-M41 (5NCME<sup>Muar</sup>), rJEV-NS1-3<sup>Muar</sup>-M41 (NS1-3<sup>Muar</sup>), rJEV- NS4A-5<sup>Muar</sup>-M41 (NS4A-5<sup>Muar</sup>), rJEV-NS5-3N<sup>Muar</sup>-M41 (NS5-3N<sup>Muar</sup>), rJEV-5NCM<sup>Muar</sup>-M41 (5NCM<sup>Muar</sup>), rJEV-E<sup>Muar</sup>-M41 (E<sup>Muar</sup>), rJEV-5NCME<sup>XZ0934</sup>-M41 (5NCME<sup>XZ0934</sup>), rJEV-5NCM<sup>XZ0934</sup>-M41 (5NCM<sup>XZ0934</sup>), rJEV-E<sup>XZ0934</sup>-M41 (E<sup>XZ0934</sup>), rJEV-E<sup>S123H</sup>-M41 (E<sup>S123H</sup>), rJEV- E<sup>Muar&#x02212;H123S</sup>-M41 (E<sup>Muar&#x02212;H123S</sup>), rJEV-E<sup>XZ0934-H123S</sup>-M41 (E<sup>XZ0934-H123S</sup>), rJEV-C<sup>Muar</sup>-M41 (C<sup>Muar</sup>), and rJEV-prM<sup>Muar</sup>-M41 (prM<sup>Muar</sup>), were constructed in the Mie/41/2002 backbone, as described previously (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>) (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). Briefly, the regions of the infectious cDNA clone rJEV (Mie/41/2002)/pMW119 were replaced with the corresponding regions of the Muar and XZ0934 genomes (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). The cDNA fragments of Muar and XZ0934 were amplified by one-step RT-PCR using PrimeScript II High Fidelity RT-PCR kit (Takara Bio, Shiga, Japan) and the primers listed in Supplementary Table&#x000a0;S1. A partial cDNA fragment of the XZ0934 strain (5&#x02032;-NCR-C-prM-E regions, 2412 nucleotides, GenBank accession no. <ext-link ext-link-type="uri" xlink:href="ncbi-n:JF915894" id="intref0015">JF915894</ext-link>) was synthesized by Integrated DNA Technologies (Skokie, IL). The amplified fragments were inserted into the corresponding regions by conventional molecular cloning methods using the In-Fusion Cloning system (Takara Bio). The single missense mutations, E<sup>S123H</sup>, E<sup>Muar&#x02212;H123S</sup>, and E<sup>XZ0934-H123S</sup>, were introduced into the rJEV (Mie/41/2002)/pMW119, rJEV-E<sup>Muar</sup>-M41/pMW119, and rJEV-E<sup>XZ0934</sup>-M41/pMW119 strains, respectively, by inverse PCR-based site-directed mutagenesis (<xref rid="bib34" ref-type="bibr">Tajima et&#x000a0;al., 2006</xref>). The nucleotide sequence of the viral genome region of the recombinant clones were examined after amplification of the plasmids in <italic>E.&#x000a0;coli</italic> STBL2 (Thermo Fisher Scientific). The recombinant viruses were recovered by transfecting the Vero cells with <italic>in vitro</italic>-transcribed recombinant viral RNA, as previously described (<xref rid="bib34" ref-type="bibr">Tajima et&#x000a0;al., 2006</xref>). The nucleotide sequence of the recombinant virus was also determined; no nucleotide mutation was detected.<fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>Schematic representation of the genomic structure of the mutant Japanese encephalitis viruses (JEVs) used in this study. The regions derived from GI Mie/41/2002, GV Muar, and GV XZ0934 strains are shown in blue, red, and orange, respectively. Numbers indicate nucleotide positions on the Mie/41/2002 genome. There is no difference in the amino acids at nucleotide positions 936 and 978 among the original three strains.</p></caption><alt-text id="alttext0020">Fig.&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec2.5"><label>2.5</label><title>Plaque formation assay and analysis of the growth kinetics</title><p id="p0055">For the plaque formation assay, Vero cells (3 &#x000d7; 10<sup>5</sup> cells/well) were plated in 12-well plates and inoculated with the viruses for 1h at 35&#x02013;37 &#x000b0;C. A MEM-based overlay medium containing 1% methyl cellulose and 2% fetal bovine serum was added to the wells and the cells and then incubated for 5 days at 35&#x02013;37 &#x000b0;C. The cells were fixed using a 10% formalin-PBS solution and subsequently stained with methylene blue as described previously (<xref rid="bib34" ref-type="bibr">Tajima et&#x000a0;al., 2006</xref>).</p><p id="p0060">The growth of the JEV strains was analyzed as described previously (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>). Briefly, cells (N18 and IMR-32) were plated in 6-well culture plates and infected with the JEV in MEM supplemented with 2% FBS at a multiplicity of infection of 0.1 plaque forming units (PFU)/cell. Small aliquots of the media were removed at one-day intervals, and their infectious viral titers were determined by a plaque formation assay on Vero cells as described above.</p></sec><sec id="sec2.6"><label>2.6</label><title>Mouse challenge and sample collection</title><p id="p0065">All animal experiments were conducted in accordance with the Fundamental Rules for Animal Experiments of our institute. Female ddY mice (3-weeks old) were purchased from Japan SLC, Inc. (Shizuoka, Japan) and maintained in a specific-pathogen-free environment.</p><p id="p0070">For virulence analysis, groups of mice (n = 8 or 10) were inoculated intraperitoneally with 1 &#x000d7; 10<sup>3</sup>, 1 &#x000d7; 10<sup>4</sup>, or 1 &#x000d7; 10<sup>5</sup> PFU (100 &#x003bc;L) of JEV virus solution diluted with a 0.9% NaCl solution. The mice were observed, and the body weight of mice was measured every day for 18 days after inoculation to determine the survival rates. The survival curves were compared using BellCurve for Excel (Social Survey Research Information, Tokyo, Japan) employing the log-rank (Mantel&#x02013;Cox) test. A <italic>P</italic>-value &#x0003c; 0.01 was considered significant.</p><p id="p0075">For sample collection, groups of mice (n = 5 or 6) were inoculated intraperitoneally with 1 &#x000d7; 10<sup>4</sup> PFU (100 &#x003bc;L) of JEV solutions. Serum, brain, and spleen were collected from the mice, and the titer and RNA levels of the infectious virus in the samples were measured as described below. Tissue weights were determined, and the tissues were homogenized in 500 &#x003bc;L of MEM with 2% FBS and the homogenate was used for further analyses.</p></sec><sec id="sec2.7"><label>2.7</label><title>Measurement of viral titer</title><p id="p0080">Viral titers for each sample were determined by plaque forming assay as described above and then statistically compared by using BellCurve for Excel, employing the Mann&#x02013;Whitney U test. A <italic>P</italic>-value &#x0003c; 0.01 was considered significant.</p></sec><sec id="sec2.8"><label>2.8</label><title>Measurement of viral-genome copy number by using real-time RT-PCR</title><p id="p0085">Total RNA was extracted from each tissue sample by using a High Pure Viral RNA Purification Kit (Roche Diagnostics, Mannheim, Germany). JEV RNA was quantified by quantitative real-time RT-PCR with Fast Virus One-Step Master Mix (Thermo Fisher Scientific). The JEV genome was amplified using primers JE-Multi-f (5&#x02032;-AGAACGGAAGAYAACCATGACTAAA-3&#x02032;) and JE-Multi-r (5&#x02032;-CCGCGTTTCAGCATATTGAT-3&#x02032;), and probe JE-Multi (5&#x02032;-FAM-ACCAGGAGGGCCCGG-MGB-3&#x02032;) (<xref rid="bib30" ref-type="bibr">Shirato et&#x000a0;al., 2005</xref>). Genome copy numbers were statistically compared using BellCurve for Excel, employing the Mann&#x02013;Whitney U test.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Pathogenicity of the GI-GV intertypic mutants, 5NCME<sup>Muar</sup>, NS1-3<sup>Muar</sup>, NS4A-5<sup>Muar</sup>, and NS5-3N<sup>Muar</sup>, in mice</title><p id="p0090">We previously showed that the GV strain Muar is significantly more pathogenic than the GI strain Mie/41/2002 (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). To specify the genomic region on GV involved in its high virulence phenotype, four intertypic mutant viruses incorporating the Mie/41/2002 backbone, 5NCME<sup>Muar</sup>, NS1-3<sup>Muar</sup>, NS4A-5<sup>Muar</sup>, and NS5-3N<sup>Muar</sup>, were produced (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). Mice were intraperitoneally inoculated with Mie/41/2002, Muar, and the four mutant viruses (1 &#x000d7; 10<sup>4</sup> PFU/mouse) and observed for 18 days (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 1). None of the mice inoculated with Mie/41/2002 died, but all the eight mice inoculated with Muar died. All the eight mice inoculated with 5NCME<sup>Muar</sup> died, and the mean time to death of 5NCME<sup>Muar</sup>-inoculated mice was equivalent to that of Muar-inoculated mice. In contrast, in the case of both the NS1-3<sup>Muar</sup>- and NS5-3N<sup>Muar</sup>-inoculated mice, two out of eight mice died. Although a loss in body weight was observed in some NS4A-5<sup>Muar</sup>-inoculated mice (Supplementary Fig.&#x000a0;S2), these mice did not die. These results indicate that the 5&#x02032;-NCR-C-prM-E region of Muar is mainly responsible for its high virulence.<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Mouse neuroinvasiveness of recombinant JEV strains.</p></caption><alt-text id="alttext0050">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Experiment no.</th><th>Virus</th><th>Dose (pfu/mouse)</th><th>Survival<xref rid="tbl1fna" ref-type="table-fn">a</xref></th><th>Mean time to death (day)</th><th><italic>P</italic> value<xref rid="tbl1fnb" ref-type="table-fn">b</xref> (vs Mie/41/2002)</th><th><italic>P</italic> value<xref rid="tbl1fnb" ref-type="table-fn">b</xref> (vs Muar)</th><th><italic>P</italic> value<xref rid="tbl1fnb" ref-type="table-fn">b</xref> (vs rJEV-E<sup>Muar</sup>-M41)</th><th><italic>P</italic> value<xref rid="tbl1fnb" ref-type="table-fn">b</xref> (vs rJEV-E<sup>XZ0934</sup>-M41)</th><th><italic>P</italic> value<xref rid="tbl1fnb" ref-type="table-fn">b</xref> (vs rJEV-5NCM<sup>Muar</sup>-M41)</th></tr></thead><tbody><tr><td rowspan="6">1</td><td>Mie/41/2002</td><td>10<sup>4</sup></td><td>8/8</td><td>-</td><td>-</td><td>&#x0003c;0.001*</td><td/><td/><td/></tr><tr><td>Muar</td><td>10<sup>4</sup></td><td>0/8</td><td>7.8</td><td>&#x0003c;0.001*</td><td>-</td><td/><td/><td/></tr><tr><td>rJEV-5NCME<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>0/8</td><td>7.8</td><td>&#x0003c;0.001*</td><td>1.0</td><td/><td/><td/></tr><tr><td>rJEV-NS1-3<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>6/8</td><td>16.0</td><td>0.1435</td><td>&#x0003c;0.001*</td><td/><td/><td/></tr><tr><td>rJEV-NS4A-5<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>8/8</td><td>-</td><td>1.0</td><td>&#x0003c;0.001*</td><td/><td/><td/></tr><tr><td>rJEV-NS5-3N<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>6/8</td><td>15.6</td><td>0.1435</td><td>&#x0003c;0.001*</td><td/><td/><td/></tr><tr><td colspan="10">&#x02028;&#x02028;</td></tr><tr><td rowspan="8">2</td><td>Mie/41/2002</td><td>10<sup>4</sup></td><td>8/8</td><td>-</td><td>-</td><td/><td/><td/><td/></tr><tr><td>rJEV-5NCME<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>0/8</td><td>6.4</td><td>&#x0003c;0.001*</td><td/><td/><td/><td/></tr><tr><td>rJEV-5NCM<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>1/8</td><td>8.5</td><td>&#x0003c;0.001*</td><td/><td/><td/><td/></tr><tr><td>rJEV-E<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>1/8</td><td>8.6</td><td>&#x0003c;0.001*</td><td/><td/><td/><td/></tr><tr><td>rJEV-5NCME<sup>XZ0934</sup>-M41</td><td>10<sup>4</sup></td><td>0/8</td><td>6.3</td><td>&#x0003c;0.001*</td><td/><td/><td/><td/></tr><tr><td>rJEV-5NCM<sup>XZ0934</sup>-M41</td><td>10<sup>4</sup></td><td>2/8</td><td>10.9</td><td>0.002*</td><td/><td/><td/><td/></tr><tr><td>rJEV-E<sup>XZ0934</sup>-M41</td><td>10<sup>4</sup></td><td>1/8</td><td>10.1</td><td>&#x0003c;0.001*</td><td/><td/><td/><td/></tr><tr><td>rJEV-E<sup>S123H</sup>-M41</td><td>10<sup>4</sup></td><td>3/8</td><td>11.3</td><td>0.009*</td><td/><td/><td/><td/></tr><tr><td colspan="10">&#x02028;&#x02028;</td></tr><tr><td rowspan="4">3</td><td>Mie/41/2002</td><td>10<sup>3</sup></td><td>9/10</td><td>17.0</td><td>-</td><td/><td/><td/><td/></tr><tr><td>rJEV-E<sup>S123H</sup>-M41</td><td>10<sup>3</sup></td><td>10/10</td><td>-</td><td>0.3173</td><td/><td/><td/><td/></tr><tr><td>Mie/41/2002</td><td>10<sup>5</sup></td><td>5/10</td><td>12.6</td><td>-</td><td/><td/><td/><td/></tr><tr><td>rJEV-E<sup>S123H</sup>-M41</td><td>10<sup>5</sup></td><td>0/10</td><td>6.8</td><td>0.007*</td><td/><td/><td/><td/></tr><tr><td colspan="10">&#x02028;&#x02028;</td></tr><tr><td rowspan="4">4</td><td>rJEV-E<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>3/10</td><td>10.6</td><td/><td/><td>-</td><td/><td/></tr><tr><td>rJEV-E<sup>Muar-H123S</sup>-M41</td><td>10<sup>4</sup></td><td>1/10</td><td>9.0</td><td/><td/><td>0.4773</td><td/><td/></tr><tr><td>rJEV-E<sup>XZ0934</sup><sup>-</sup>M41</td><td>10<sup>4</sup></td><td>3/10</td><td>10.5</td><td/><td/><td/><td>-</td><td/></tr><tr><td>rJEV-E<sup>XZ0934</sup><sup>-H123S</sup>-M41</td><td>10<sup>4</sup></td><td>4/10</td><td>13.0</td><td/><td/><td/><td>0.38</td><td/></tr><tr><td colspan="10">&#x02028;&#x02028;</td></tr><tr><td rowspan="3">5</td><td>rJEV-5NCM<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>2/8</td><td>11.0</td><td/><td/><td/><td/><td>-</td></tr><tr><td>rJEV-C<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>7/8</td><td>16.8</td><td/><td/><td/><td/><td>0.021</td></tr><tr><td>rJEV-prM<sup>Muar</sup>-M41</td><td>10<sup>4</sup></td><td>2/8</td><td>11.8</td><td/><td/><td/><td/><td>0.9093</td></tr></tbody></table><table-wrap-foot><fn id="tbl1fna"><label>a</label><p id="ntpara0010">No. of mice surviving/no. of mice inoculated.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fnb"><label>b</label><p id="ntpara0015"><italic>P</italic> value relative to Mie/41/2002, Muar, rJEV-E<sup>Muar</sup>-M41, rJEV-E<sup>XZ0934</sup>-M41, and rJEV-5NCM<sup>Muar</sup>-M41 by log-rank test. Asterisks indicate statistical significance (*, <italic>p</italic> &#x0003c; 0.01).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.2"><label><italic>3.2</italic></label><title><italic>In vitro</italic> growth characteristics of the 5NCME<sup>Muar</sup> mutant</title><p id="p0095">Next, the <italic>in vitro</italic> growth properties of the 5NCME<sup>Muar</sup> mutant were examined. Previously, we have shown that the growth ability of Muar in mouse neuroblastoma N18 cells is significantly lower than that of Mie/41/2002 (<xref rid="bib35" ref-type="bibr">Tajima et&#x000a0;al., 2015</xref>). Although the growth kinetics of 5NCME<sup>Muar</sup> in N18 cells were very similar to those of Mie/41/2002, these were clearly higher than those observed for Muar (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>A). However, in human neuroblastoma IMR-32 cells, no significant difference was observed in the proliferation rates among the three strains (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B). These results suggest that the replacement of 5&#x02032;-NCR-C-prM-E region of Mie/41/2002 by that of Muar does not affect the <italic>in vitro</italic> growth characteristics of Mie/41/2002.<fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p>Growth properties of GI Mie/41/2002, GV Muar, and mutant rJEV-5NCME<sup>Muar</sup>-M41 in mouse neuroblastoma N18 (A) and human neuroblastoma IMR-32 (B) cells. Values represent the mean and standard deviation for three independent tests.</p></caption><alt-text id="alttext0025">Fig.&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec3.3"><label>3.3</label><title>Pathogenicity of the 5NCM<sup>Muar</sup>, E<sup>Muar</sup>, 5NCME<sup>XZ0934</sup>, 5NCM<sup>XZ0934</sup>, and E<sup>XZ0934</sup> mutants in mice</title><p id="p0100">To identify the genes involved in the high virulence of Muar, additional intertypic viruses, 5NCM<sup>Muar</sup> and E<sup>Muar</sup>, which contain the 5&#x02032;-NCR-C-prM region and only the E region of Muar, respectively, were produced and inoculated into mice (1 &#x000d7; 10<sup>4</sup> PFU/mouse) (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>; <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 2). Seven out of eight mice inoculated with 5NCM<sup>Muar</sup> and E<sup>Muar</sup> died, and the mean times to death of the two groups were very similar, indicating that both the 5&#x02032;-NCR-C-prM and E regions are involved in the virulence of Muar.</p><p id="p0105">Three novel mutant viruses, 5NCME<sup>XZ0934</sup>, 5NCM<sup>XZ0934</sup>, and E<sup>XZ0934</sup>, which contain the 5&#x02032;-NCR-C-prM-E region, 5&#x02032;-NCR-C-prM region, and only the E region of the recent GV isolate XZ0934, respectively, were produced and then inoculated into mice (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>; <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 2). All the eight mice inoculated with 5NCME<sup>XZ0934</sup> or 5NCME<sup>Muar</sup> died, and the mean time to death of 5NCME<sup>XZ0934</sup>-inoculated mice was very similar to that of the 5NCME<sup>Muar</sup>-inoculated mice. Six and seven out of eight mice inoculated with 5NCM<sup>XZ0934</sup> and E<sup>XZ0934</sup>, respectively, died, and the mean times of death in the two mice groups were similar. These results imply that the 5&#x02032;-NCR-C-prM-E region in XZ0934 also has the ability to increase the virulence of Mie/41/2002.</p></sec><sec id="sec3.4"><label>3.4</label><title>Growth of the Mie/41/2002, Muar, 5NCM<sup>Muar</sup>, and E<sup>Muar</sup> strains in mice</title><p id="p0110">Viremia and infectious virus levels in Mie/41/2002-, Muar-, 5NCM<sup>Muar</sup>- and E<sup>Muar</sup>-inoculated mice were examined. At two days after inoculation, no infectious virus was detected in the brain and spleen in all the four groups, whereas viremia was seen in all the groups (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>A-C). The viremia in the Muar-inoculated mice was higher but not as much as compared to the other strain-inoculated mice. Viral RNAs were detected in most of the samples; however, the levels were higher in Muar- and 5NCM<sup>Muar</sup>-inoculated mice (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>D-F).<fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p>Levels of infectious virus and viral RNA at two days after inoculation in JEV-infected mice. Mice inoculated with Mie/41/2002 (n = 5), Muar (n = 5), rJEV-5NCM<sup>Muar</sup>-M41 (5NCM-Muar) (n = 5), or rJEV-E<sup>Muar</sup>-M41 (E-Muar) (n = 5) were euthanized at two days after inoculation, and serum, brain, and spleen samples were collected. Sera and tissue homogenates were used to quantify the titer of the infectious virus (PFU/mL or g) (A&#x02013;C) and the viral genome (genome copies/mL or g) (D&#x02013;F). Dotted line: detection limit; solid lines: mean values. Significance was analyzed using the Mann&#x02013;Whitney U test (*<italic>p</italic> &#x0003c; 0.01).</p></caption><alt-text id="alttext0030">Fig.&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p><p id="p0115">At five days post infection, no infectious virus was detected in any of the serum and spleen samples (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>A and C). In contrast, higher titers of infectious virus were detected in the brains of mice inoculated with Muar, 5NCM<sup>Muar</sup>, and E<sup>Muar</sup> compared with Mie/41/2002 (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>B). In particular, the titers were significantly higher for Muar- and 5NCM<sup>Muar</sup>-inoculated mice. Viral RNA was detected in most of the brain and spleen samples from the mice inoculated with the JEVs, and the levels of viral RNA were higher in the Muar and mutant virus-inoculated mice than in the Mie/41/2002-inoculated mice (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>D-F).<fig id="fig4"><label>Fig.&#x000a0;4</label><caption><p>Levels of infectious virus and viral RNA at five days after inoculation in JEV-infected mice. Mice inoculated with Mie/41/2002 (n = 6), Muar (n = 6), rJEV-5NCM<sup>Muar</sup>-M41 (5NCM-Muar) (n = 6), or rJEV-E<sup>Muar</sup>-M41 (E-Muar) (n = 6) were euthanized at five days after inoculation, and serum, brain, and spleen samples were collected. Sera and tissue homogenates were tested for quantifying the infectious virus titer (PFU/mL or g) (A&#x02013;C) and the viral genome (genome copies/mL or g) (D&#x02013;F). Dotted line: detection limit; solid lines: mean values. Significance was analyzed using the Mann&#x02013;Whitney U test (*<italic>p</italic> &#x0003c; 0.01).</p></caption><alt-text id="alttext0035">Fig.&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p></sec><sec id="sec3.5"><label>3.5</label><title>Effect of single amino acid substitutions at position 123 of the JEV E protein on the virulence in mice</title><p id="p0120">We previously reported that the amino acid at position 123 of JEV E (E123) is involved in the pathogenicity of JEV in mice (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>). An amino acid substitution of E123 from serine to arginine increases the virulence of Mie/41/2002, whereas a serine-to-asparagine replacement at that site does not alter the virulence (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>) (<xref rid="bib41" ref-type="bibr">Yamaguchi et&#x000a0;al., 2013</xref>). In most of GI, GII, GIII, and GIV JEV strains, the E123 was serine or asparagine (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>), whereas a histidine residue at E123 was conserved in the GV JEV strains. To assess whether the histidine residue at E123 in the Muar and XZ0934 strains is associated with their virulence, a mutant virus E<sup>S123H</sup> was prepared in which only the serine at E123 in the Mie/41/2002 was substituted with histidine, and the virus was then inoculated into mice (1 &#x000d7; 10<sup>4</sup> PFU/mouse) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 2). Five out of the eight inoculated mice died, and the mortality rate of the mice group was significantly higher than that of the Mie/41/2002-inoculated mice. The amount of inoculated virus was also changed to examine the virulence of the E<sup>S123H</sup> mutant in mice (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 3). None of the mice died at low concentrations (1 &#x000d7; 10<sup>3</sup> PFU/mouse) of the mutant, but all 10 mice inoculated at high concentrations (1 &#x000d7; 10<sup>5</sup> PFU/mouse) died, and the number of dead mice in the group was significantly higher than in the Mie/41/2002-inoculated mice group. Additionally, the time to death of the E<sup>S123H</sup>-inoculated mice was about half as long as that of the Mie/41/2002-inoculated mice. These results suggest that the histidine residue at E123 on GV JEV E protein is associated with the higher virulence of GV JEV.<fig id="fig5"><label>Fig.&#x000a0;5</label><caption><p>Alignment of partial amino acid sequences of Japanese encephalitis virus (JEV) strains. A partial sequence of the E region between aa 110 and aa 149 is shown. The amino acid sequence of GI Mie/41/2002 is used as a reference sequence. The arrowhead indicates the residue at position 123 of the E protein.</p></caption><alt-text id="alttext0040">Fig.&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p><p id="p0125">To investigate the possibility of involvement in higher virulence of amino acid locations in the GV JEV E protein other than E123, two additional mutant viruses, E<sup>Muar&#x02212;H123S</sup> and E<sup>XZ0934-H123S</sup>, were produced and inoculated into mice (1 &#x000d7; 10<sup>4</sup> PFU/mouse) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 4). No significant differences in the survival rate and time to death were observed between the E<sup>Muar</sup>-infected and E<sup>Muar&#x02212;H123S</sup>-infected mice, or between the E<sup>XZ0934</sup>-infected and E<sup>XZ0934-H123S</sup>-infected mice. These results suggest that not only E123, but other sites in the GV JEV E protein, contribute to the higher pathogenicity of GV JEV in mice.</p></sec><sec id="sec3.6"><label>3.6</label><title>Pathogenicity of the C<sup>Muar</sup> and prM<sup>Muar</sup> mutants in mice</title><p id="p0130">To clarify whether the C or prM protein of Muar is responsible for the high pathogenicity of this strain, the two mutant viruses, C<sup>Muar</sup> and prM<sup>Muar</sup>, were produced and the virulence of these mutants in mice was examined (1 &#x000d7; 10<sup>4</sup> PFU/mouse) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>; Supplementary Fig.&#x000a0;S1, Experiment 5). Six out of eight mice inoculated with 5NCM<sup>Muar</sup> and prM<sup>Muar</sup> died, and the mortality rates of the two groups were higher than that of C<sup>Muar</sup>-inoculated mice although no clear statistical significance was observed in the survival rates between C<sup>Muar</sup>- and 5NCM<sup>Muar</sup>-inoculated mice groups (<italic>p</italic> = 0.021). This indicates that the prM protein of Muar is also associated with the higher virulence of this strain.</p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0135">We have previously shown that the GV strain Muar is more pathogenic in mice than the GI strain Mie/41/2002. In this study, we attempted to determine which region is involved in the difference in pathogenicity in mice between the strains. It has been known that structural proteins, especially the E protein, are mainly involved in determining the virulence of JEV (<xref rid="bib25" ref-type="bibr">Ni and Barrett, 1998</xref>) (<xref rid="bib40" ref-type="bibr">Wu and Lee, 2001</xref>) (<xref rid="bib20" ref-type="bibr">Monath et&#x000a0;al., 2002</xref>) (<xref rid="bib39" ref-type="bibr">Wu et&#x000a0;al., 2003</xref>) (<xref rid="bib5" ref-type="bibr">Chiou et&#x000a0;al., 2005</xref>) (<xref rid="bib21" ref-type="bibr">Mori et&#x000a0;al., 2005</xref>) (<xref rid="bib4" ref-type="bibr">Chambers et&#x000a0;al., 2007</xref>) (<xref rid="bib13" ref-type="bibr">Kim et&#x000a0;al., 2008</xref>) (<xref rid="bib47" ref-type="bibr">Zhou et&#x000a0;al., 2018</xref>). We also demonstrated that the E protein is involved in the high virulence of the GIII strain Beijing-1 (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>). In addition, mutations of amino acids in E protein have been found in live-attenuated JE vaccines and attenuated JEVs (<xref rid="bib32" ref-type="bibr">Sumiyoshi et&#x000a0;al., 1995</xref>) (<xref rid="bib24" ref-type="bibr">Ni and Barrett, 1996</xref>) (<xref rid="bib45" ref-type="bibr">Zhao et&#x000a0;al., 2005</xref>) (<xref rid="bib17" ref-type="bibr">Liang et&#x000a0;al., 2009</xref>) (<xref rid="bib43" ref-type="bibr">Yu, 2010</xref>) (<xref rid="bib46" ref-type="bibr">Zheng et&#x000a0;al., 2018</xref>). These findings suggest that the E region may also be related to the high virulence of GV JEV. A French group showed that the GV XZ0934 strain is more pathogenic in mice than the GIII RP-9 strain and that the structural protein region of XZ0934 is involved in its higher pathogenicity (<xref rid="bib6" ref-type="bibr">de Wispelaere et&#x000a0;al., 2015</xref>). However, in this study we did not investigate which of the three structural proteins was associated with the high virulence. Herein, analyses of the intertypic viruses proved that the E and prM regions are involved in the higher pathogenicity of GV JEV.</p><p id="p0140">In the E protein, there are about 8% differences in amino acids (about 40 residues) between Mie/41/2002 and GV JEVs. Previous studies on the identification of the sites involved in the attenuation of GIII JEV strains suggested that amino acid changes at positions 107, 138, 176, 177, 244, 264, 279, 315, 366, and 439 of E may be involved (<xref rid="bib45" ref-type="bibr">Zhao et&#x000a0;al., 2005</xref>) (<xref rid="bib10" ref-type="bibr">Gromowski et&#x000a0;al., 2015</xref>; <xref rid="bib17" ref-type="bibr">Liang et&#x000a0;al., 2009</xref>) (<xref rid="bib42" ref-type="bibr">Yang et&#x000a0;al., 2017</xref>) (<xref rid="bib47" ref-type="bibr">Zhou et&#x000a0;al., 2018</xref>) (<xref rid="bib46" ref-type="bibr">Zheng et&#x000a0;al., 2018</xref>). Nine out of 10 amino acid residues at these positions are identical among the three strains used in this study. Amino acid residue at position 366 is different in Mie/41/2002 (serine) and GV JEVs (alanine); however, the residue in GV JEVs is the same as that in the attenuated strain SA-14-14-2 (<xref rid="bib10" ref-type="bibr">Gromowski et&#x000a0;al., 2015</xref>). There are more than 20 amino acid residues unique to GV JEVs in the E region, including E123. The E123 amino acid is serine or asparagine in GI, GII, GIII, and GIV JEV, but histidine in GV JEV (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>). In this study, we show that a serine-to-histidine substitution at E123 (E<sup>S123H</sup>) increased the virulence of Mie/41/2002. The E protein forms head-to-tail homodimers and consists of three domains: domain I, II, and III. E123 is located in domain II, which is important for homodimerization of the E protein, and amino acid mutations in domain II may influence the virulence by affecting low pH conformational transitions (<xref rid="bib28" ref-type="bibr">Rey et&#x000a0;al., 1995</xref>) (<xref rid="bib14" ref-type="bibr">Kolaskar and Kulkarni-Kale, 1999</xref>) (<xref rid="bib26" ref-type="bibr">Nybakken et&#x000a0;al., 2006</xref>). It has been suggested that protonation of histidine residues in the E protein at acidic pH affects the structural transition and membrane fusion in the lifecycle of flavivirus (<xref rid="bib8" ref-type="bibr">Fritz et&#x000a0;al., 2008</xref>) (<xref rid="bib22" ref-type="bibr">Nelson et&#x000a0;al., 2009</xref>). In contrast to serine, which belongs to the polar, uncharged side chain group, histidine is classified in the positively-charged side chain group, which also includes arginine. We previously showed that a serine-to-arginine substitution at E123 (E<sup>S123R</sup>) increases the virulence of JEV (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>), suggesting that a substitution of serine at E123 to a positively-charged amino acid may contribute to increased virulence of JEV in mice. Crystal structure analysis of the JEV E protein shows that E123 in the domain II is located on the surface of the JEV virion (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref>) (<xref rid="bib19" ref-type="bibr">Luca et&#x000a0;al., 2012</xref>). It is possible that the domain II interacts with cellular factors and amino acid residue of E123 influences the affinity of factors for the domain II. Our report also indicated that the E<sup>S123R</sup> mutation increases the proliferative capacity in mouse neuroblastoma N18 cells (<xref rid="bib33" ref-type="bibr">Tajima et&#x000a0;al., 2010</xref>). However, the proliferation ability of the Muar strain in N18 cells is lower than that of Mie/41/2002, whereas the growth kinetics of the 5NCME<sup>Muar</sup> mutant were similar to those of Mie/41/2002. These results suggest that the proliferative potential of JEV in N18 cells is not necessarily reflective of its virulence in mice.<fig id="fig6"><label>Fig.&#x000a0;6</label><caption><p>Molecular graphics of the Japanese encephalitis virus (JEV) E protein (SA-14-14-2 strain, PDB accession code <ext-link ext-link-type="uri" xlink:href="pdb:3P54" id="intref0025">3P54</ext-link>). A: asymmetric unit (monomer). B and C: biological unit (tetramer). Yellow balls: amino acid residue (serine) at position 123 of E protein.</p></caption><alt-text id="alttext0045">Fig.&#x000a0;6</alt-text><graphic xlink:href="gr6"/></fig></p><p id="p0145">The virulence of the E<sup>S123H</sup> mutant was slightly lower than that of Muar and intertypic 5NCME and E mutants. Moreover, the virulence of E<sup>Muar&#x02212;H123S</sup> and E<sup>XZ0934-H123S</sup> mutants was similar to that of E<sup>Muar</sup> and E<sup>XZ0934</sup> mutants, respectively. These data imply that the histidine residue at E123 is not sufficient to explain the high virulence of GV JEV. Thus, not only the amino acid residue at E123, but other residues unique to GV JEV (for example, E120, E122, E128, E141, and E149 in <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>) may also be involved in the high virulence of GV JEV, and the residues may cooperate with each other to promote the high pathogenicity of GV JEV.</p><p id="p0150">In the present study, we demonstrate that in addition to the E region, the prM region also possesses a site responsible for the high virulence of GV JEV. There are about 10% differences in prM amino acid residues between the Mie/41/2002 and GV strains. Little is known about how the prM protein contributes to the virulence of JEV. However, recent reports suggest that prM of <italic>Zika virus</italic> is involved in its pathogenicity in mice (<xref rid="bib44" ref-type="bibr">Yuan et&#x000a0;al., 2017</xref>) (<xref rid="bib11" ref-type="bibr">Kato et&#x000a0;al., 2017</xref>). The prM of JEV contains an N-linked glycosylation site that is crucial for the pathogenesis of JEV, although the glycosylation motif is conserved among JEV genotypes (<xref rid="bib13" ref-type="bibr">Kim et&#x000a0;al., 2008</xref>). The prM protein interacts with the E proteins to form prM&#x02013;E heterodimers, which are required for the folding of the E protein and the formation of immature virions (<xref rid="bib15" ref-type="bibr">Konishi and Mason, 1993</xref>) (<xref rid="bib18" ref-type="bibr">Lorenz et&#x000a0;al., 2002</xref>), suggesting that the replacement of the prM region might influence the assembly and maturation processes of virus particles through the E protein. Identification of the sites responsible for increased pathogenicity of the prM mutant would provide new insights into the biology and pathogenesis of JEV.</p><p id="p0155">In this study, we did not produce an intertypic mutant that has only the 5&#x02032;-NCR region of GV JEV. There are three and four nucleotide differences in the 5&#x02032;-NCR between Mie/41/2002 and Muar, and between Mie/41/2002 and XZ0934, respectively (Supplementary Fig.&#x000a0;S3). A previous report indicated that a single nucleotide substitution in the 5&#x02032;-NCR of JEV influences the virulence of JEV in mice (<xref rid="bib10" ref-type="bibr">Gromowski et&#x000a0;al., 2015</xref>). The nucleotide positions in the 5&#x02032;-NCR of GV JEV might also be associated with the pathogenicity of GV JEV.</p><p id="p0160">The number of JE patients has rapidly increased in Korea since 2010. GV JEV was first identified in Korea in 2010, and most of the JEV identified thereafter are GV strains (<xref rid="bib12" ref-type="bibr">Kim et&#x000a0;al., 2015</xref>). It is unclear whether this rise in the number of JE patients is related to the spread of GV. Invasion of GV has not been confirmed in Japan and other JE-endemic areas besides Korea. In most areas where JE epidemics occur, GI JEVs are persistent, as they were in Korea before 2010; however, GV invasion may cause a rapid shift to GV in these areas, which can increase the number of patients with JE. To prepare for a global epidemic of GV, it is important to further analyze and improve our understanding of GV JEV.</p></sec><sec id="sec5"><title>Declarations</title><sec id="sec5.1"><title>Author contribution statement</title><p id="p0165">Shigeru Tajima: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.</p><p id="p0170">Ken-ichi Shibasaki, Satoshi Taniguchi, Eri Nakayama, Takahiro Maeki: Performed the experiments.</p><p id="p0180">Chang-Kweng Lim, Masayuki Saijo: Analyzed and interpreted the data.</p></sec><sec id="sec5.2"><title>Funding statement</title><p id="p0185">This work was supported by the Research Program on Emerging and Re-emerging Infectious Diseases of the <funding-source id="gs1">Japan Agency for Medical Research and Development</funding-source> (<funding-source id="gs2">AMED</funding-source>) under Grant Number JP19fk0108035.</p></sec><sec id="sec5.3"><title>Competing interest statement</title><p id="p0190">The authors declare no conflict of interest.</p></sec><sec id="sec5.4"><title>Additional information</title><p id="p0195">No additional information is available for this paper.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Hwang</surname><given-names>E.S.</given-names></name></person-group><article-title>Changes of epidemiological characteristics of Japanese encephalitis viral infection and birds as a potential viral transmitter in Korea</article-title><source>J.&#x000a0;Korean Med. Sci.</source><volume>33</volume><year>2018</year><fpage>e70</fpage><pub-id pub-id-type="pmid">29441740</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>G.L.</given-names></name><name><surname>Hills</surname><given-names>S.L.</given-names></name><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Jacobson</surname><given-names>J.A.</given-names></name><name><surname>Hoke</surname><given-names>C.H.</given-names></name><name><surname>Hombach</surname><given-names>J.M.</given-names></name><name><surname>Marfin</surname><given-names>A.A.</given-names></name><name><surname>Solomon</surname><given-names>T.</given-names></name><name><surname>Tsai</surname><given-names>T.F.</given-names></name><name><surname>Tsu</surname><given-names>V.D.</given-names></name><name><surname>Ginsburg</surname><given-names>A.S.</given-names></name></person-group><article-title>Estimated global incidence of Japanese encephalitis: a systematic review</article-title><source>Bull. World Health Organ.</source><volume>89</volume><year>2011</year><fpage>766</fpage><lpage>774</lpage><comment>774A-774E</comment><pub-id pub-id-type="pmid">22084515</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Lei</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name><name><surname>Liang</surname><given-names>G.</given-names></name></person-group><article-title>Low protective efficacy of the current Japanese encephalitis vaccine against the emerging genotype 5 Japanese encephalitis virus</article-title><source>PLoS Neglected Trop. Dis.</source><volume>10</volume><year>2016</year><object-id pub-id-type="publisher-id">e0004686</object-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>T.J.</given-names></name><name><surname>Droll</surname><given-names>D.A.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Wold</surname><given-names>W.S.</given-names></name><name><surname>Nickells</surname><given-names>J.A.</given-names></name></person-group><article-title>JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease</article-title><source>Virology</source><volume>366</volume><year>2007</year><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17521693</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Chiou</surname><given-names>S.S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Chuang</surname><given-names>C.K.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>W.J.</given-names></name></person-group><article-title>Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface</article-title><source>J.&#x000a0;Med. Virol.</source><volume>76</volume><year>2005</year><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">15977230</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>de Wispelaere</surname><given-names>M.</given-names></name><name><surname>Frenkiel</surname><given-names>M.P.</given-names></name><name><surname>Despres</surname><given-names>P.</given-names></name></person-group><article-title>A Japanese Encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: implication of the structural proteins region in virulence</article-title><source>J.&#x000a0;Virol.</source><volume>89</volume><year>2015</year><fpage>5862</fpage><lpage>5875</lpage><pub-id pub-id-type="pmid">25787283</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Erlanger</surname><given-names>T.E.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name><name><surname>Keiser</surname><given-names>J.</given-names></name><name><surname>Utzinger</surname><given-names>J.</given-names></name><name><surname>Wiedenmayer</surname><given-names>K.</given-names></name></person-group><article-title>Past, present, and future of Japanese encephalitis</article-title><source>Emerg. Infect. Dis.</source><volume>15</volume><year>2009</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19116041</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>R.</given-names></name><name><surname>Stiasny</surname><given-names>K.</given-names></name><name><surname>Heinz</surname><given-names>F.X.</given-names></name></person-group><article-title>Identification of specific histidines as pH sensors in flavivirus membrane fusion</article-title><source>J.&#x000a0;Cell Biol.</source><volume>183</volume><year>2008</year><fpage>353</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">18936253</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Liang</surname><given-names>G.</given-names></name></person-group><article-title>Southernmost Asia is the source of Japanese encephalitis virus (genotype 1) diversity from which the viruses disperse and evolve throughout Asia</article-title><source>PLoS Neglected Trop. Dis.</source><volume>7</volume><year>2013</year><fpage>e2459</fpage></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Gromowski</surname><given-names>G.D.</given-names></name><name><surname>Firestone</surname><given-names>C.Y.</given-names></name><name><surname>Whitehead</surname><given-names>S.S.</given-names></name></person-group><article-title>Genetic determinants of Japanese encephalitis virus vaccine strain SA14-14-2 that govern attenuation of virulence in mice</article-title><source>J.&#x000a0;Virol.</source><volume>89</volume><year>2015</year><fpage>6328</fpage><lpage>6337</lpage><pub-id pub-id-type="pmid">25855730</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>F.</given-names></name><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Nakayama</surname><given-names>E.</given-names></name><name><surname>Kawai</surname><given-names>Y.</given-names></name><name><surname>Taniguchi</surname><given-names>S.</given-names></name><name><surname>Shibasaki</surname><given-names>K.</given-names></name><name><surname>Taira</surname><given-names>M.</given-names></name><name><surname>Maeki</surname><given-names>T.</given-names></name><name><surname>Lim</surname><given-names>C.K.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV/Hu/S36/Chiba/2016</article-title><source>Sci. Rep.</source><volume>7</volume><year>2017</year><fpage>16160</fpage><pub-id pub-id-type="pmid">29170504</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Cha</surname><given-names>G.W.</given-names></name><name><surname>Jeong</surname><given-names>Y.E.</given-names></name><name><surname>Lee</surname><given-names>W.G.</given-names></name><name><surname>Chang</surname><given-names>K.S.</given-names></name><name><surname>Roh</surname><given-names>J.Y.</given-names></name><name><surname>Yang</surname><given-names>S.C.</given-names></name><name><surname>Park</surname><given-names>M.Y.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>E.H.</given-names></name></person-group><article-title>Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea</article-title><source>PLoS One</source><volume>10</volume><year>2015</year><object-id pub-id-type="publisher-id">e0116547</object-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.M.</given-names></name><name><surname>Yun</surname><given-names>S.I.</given-names></name><name><surname>Song</surname><given-names>B.H.</given-names></name><name><surname>Hahn</surname><given-names>Y.S.</given-names></name><name><surname>Lee</surname><given-names>C.H.</given-names></name><name><surname>Oh</surname><given-names>H.W.</given-names></name><name><surname>Lee</surname><given-names>Y.M.</given-names></name></person-group><article-title>A&#x000a0;single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice</article-title><source>J.&#x000a0;Virol.</source><volume>82</volume><year>2008</year><fpage>7846</fpage><lpage>7862</lpage><pub-id pub-id-type="pmid">18524814</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Kolaskar</surname><given-names>A.S.</given-names></name><name><surname>Kulkarni-Kale</surname><given-names>U.</given-names></name></person-group><article-title>Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus</article-title><source>Virology</source><volume>261</volume><year>1999</year><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">10441554</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Konishi</surname><given-names>E.</given-names></name><name><surname>Mason</surname><given-names>P.W.</given-names></name></person-group><article-title>Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein</article-title><source>J.&#x000a0;Virol.</source><volume>67</volume><year>1993</year><fpage>1672</fpage><lpage>1675</lpage><pub-id pub-id-type="pmid">8437237</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.H.</given-names></name><name><surname>Fu</surname><given-names>S.H.</given-names></name><name><surname>Chen</surname><given-names>W.X.</given-names></name><name><surname>Wang</surname><given-names>H.Y.</given-names></name><name><surname>Guo</surname><given-names>Y.H.</given-names></name><name><surname>Liu</surname><given-names>Q.Y.</given-names></name><name><surname>Li</surname><given-names>Y.X.</given-names></name><name><surname>Luo</surname><given-names>H.M.</given-names></name><name><surname>Da</surname><given-names>W.</given-names></name><name><surname>Duo Ji</surname><given-names>D.Z.</given-names></name><name><surname>Ye</surname><given-names>X.M.</given-names></name><name><surname>Liang</surname><given-names>G.D.</given-names></name></person-group><article-title>Genotype v Japanese encephalitis virus is emerging</article-title><source>PLoS Neglected Trop. Dis.</source><volume>5</volume><year>2011</year><object-id pub-id-type="publisher-id">e1231</object-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J.J.</given-names></name><name><surname>Liao</surname><given-names>C.L.</given-names></name><name><surname>Liao</surname><given-names>J.T.</given-names></name><name><surname>Lee</surname><given-names>Y.L.</given-names></name><name><surname>Lin</surname><given-names>Y.L.</given-names></name></person-group><article-title>A&#x000a0;Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability</article-title><source>Vaccine</source><volume>27</volume><year>2009</year><fpage>2746</fpage><lpage>2754</lpage><pub-id pub-id-type="pmid">19366580</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>I.C.</given-names></name><name><surname>Allison</surname><given-names>S.L.</given-names></name><name><surname>Heinz</surname><given-names>F.X.</given-names></name><name><surname>Helenius</surname><given-names>A.</given-names></name></person-group><article-title>Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum</article-title><source>J.&#x000a0;Virol.</source><volume>76</volume><year>2002</year><fpage>5480</fpage><lpage>5491</lpage><pub-id pub-id-type="pmid">11991976</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Luca</surname><given-names>V.C.</given-names></name><name><surname>AbiMansour</surname><given-names>J.</given-names></name><name><surname>Nelson</surname><given-names>C.A.</given-names></name><name><surname>Fremont</surname><given-names>D.H.</given-names></name></person-group><article-title>Crystal structure of the Japanese encephalitis virus envelope protein</article-title><source>J.&#x000a0;Virol.</source><volume>86</volume><year>2012</year><fpage>2337</fpage><lpage>2346</lpage><pub-id pub-id-type="pmid">22156523</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Monath</surname><given-names>T.P.</given-names></name><name><surname>Arroyo</surname><given-names>J.</given-names></name><name><surname>Levenbook</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>Z.X.</given-names></name><name><surname>Catalan</surname><given-names>J.</given-names></name><name><surname>Draper</surname><given-names>K.</given-names></name><name><surname>Guirakhoo</surname><given-names>F.</given-names></name></person-group><article-title>Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines</article-title><source>J.&#x000a0;Virol.</source><volume>76</volume><year>2002</year><fpage>1932</fpage><lpage>1943</lpage><pub-id pub-id-type="pmid">11799188</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Okabayashi</surname><given-names>T.</given-names></name><name><surname>Yamashita</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Wakita</surname><given-names>T.</given-names></name><name><surname>Yasui</surname><given-names>K.</given-names></name><name><surname>Hasebe</surname><given-names>F.</given-names></name><name><surname>Tadano</surname><given-names>M.</given-names></name><name><surname>Konishi</surname><given-names>E.</given-names></name><name><surname>Moriishi</surname><given-names>K.</given-names></name><name><surname>Matsuura</surname><given-names>Y.</given-names></name></person-group><article-title>Nuclear localization of Japanese encephalitis virus core protein enhances viral replication</article-title><source>J.&#x000a0;Virol.</source><volume>79</volume><year>2005</year><fpage>3448</fpage><lpage>3458</lpage><pub-id pub-id-type="pmid">15731239</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>S.</given-names></name><name><surname>Poddar</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>T.Y.</given-names></name><name><surname>Pierson</surname><given-names>T.C.</given-names></name></person-group><article-title>Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis</article-title><source>J.&#x000a0;Virol.</source><volume>83</volume><year>2009</year><fpage>12631</fpage><lpage>12635</lpage><pub-id pub-id-type="pmid">19776132</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Nerome</surname><given-names>R.</given-names></name><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Kotaki</surname><given-names>A.</given-names></name><name><surname>Lim</surname><given-names>C.K.</given-names></name><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Sugiyama</surname><given-names>A.</given-names></name><name><surname>Yamauchi</surname><given-names>A.</given-names></name><name><surname>Yano</surname><given-names>T.</given-names></name><name><surname>Kameyama</surname><given-names>T.</given-names></name><name><surname>Morishita</surname><given-names>I.</given-names></name><name><surname>Kuwayama</surname><given-names>M.</given-names></name><name><surname>Ogawa</surname><given-names>T.</given-names></name><name><surname>Sahara</surname><given-names>K.</given-names></name><name><surname>Ikegaya</surname><given-names>A.</given-names></name><name><surname>Kanda</surname><given-names>M.</given-names></name><name><surname>Hosoya</surname><given-names>Y.</given-names></name><name><surname>Itokazu</surname><given-names>K.</given-names></name><name><surname>Onishi</surname><given-names>H.</given-names></name><name><surname>Chiya</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Tabei</surname><given-names>Y.</given-names></name><name><surname>Katsuki</surname><given-names>K.</given-names></name><name><surname>Tabata</surname><given-names>K.</given-names></name><name><surname>Harada</surname><given-names>S.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name></person-group><article-title>Molecular epidemiological analyses of Japanese encephalitis virus isolates from swine in Japan from 2002 to 2004</article-title><source>J.&#x000a0;Gen. Virol.</source><volume>88</volume><year>2007</year><fpage>2762</fpage><lpage>2768</lpage><pub-id pub-id-type="pmid">17872529</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>H.</given-names></name><name><surname>Barrett</surname><given-names>A.D.</given-names></name></person-group><article-title>Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness</article-title><source>J.&#x000a0;Gen. Virol.</source><volume>77</volume><issue>Pt 7</issue><year>1996</year><fpage>1449</fpage><lpage>1455</lpage><pub-id pub-id-type="pmid">8757986</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>H.</given-names></name><name><surname>Barrett</surname><given-names>A.D.</given-names></name></person-group><article-title>Attenuation of Japanese encephalitis virus by selection of its&#x000a0;mouse brain membrane receptor preparation escape variants</article-title><source>Virology</source><volume>241</volume><year>1998</year><fpage>30</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9454714</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Nybakken</surname><given-names>G.E.</given-names></name><name><surname>Nelson</surname><given-names>C.A.</given-names></name><name><surname>Chen</surname><given-names>B.R.</given-names></name><name><surname>Diamond</surname><given-names>M.S.</given-names></name><name><surname>Fremont</surname><given-names>D.H.</given-names></name></person-group><article-title>Crystal structure of the West Nile virus envelope glycoprotein</article-title><source>J.&#x000a0;Virol.</source><volume>80</volume><year>2006</year><fpage>11467</fpage><lpage>11474</lpage><pub-id pub-id-type="pmid">16987985</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="book" id="sref27"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>T.C.</given-names></name><name><surname>Diamond</surname><given-names>M.S.</given-names></name></person-group><chapter-title>Flaviviruses</chapter-title><person-group person-group-type="editor"><name><surname>Knipe</surname><given-names>D.M.H.</given-names></name><name><surname>P. M.</surname></name></person-group><source>Fields Virology</source><edition>6 ed.</edition><year>2013</year><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Philadelphia</publisher-loc><fpage>747</fpage><lpage>794</lpage></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Rey</surname><given-names>F.A.</given-names></name><name><surname>Heinz</surname><given-names>F.X.</given-names></name><name><surname>Mandl</surname><given-names>C.</given-names></name><name><surname>Kunz</surname><given-names>C.</given-names></name><name><surname>Harrison</surname><given-names>S.C.</given-names></name></person-group><article-title>The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution</article-title><source>Nature</source><volume>375</volume><year>1995</year><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">7753193</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Schuh</surname><given-names>A.J.</given-names></name><name><surname>Ward</surname><given-names>M.J.</given-names></name><name><surname>Leigh Brown</surname><given-names>A.J.</given-names></name><name><surname>Barrett</surname><given-names>A.D.</given-names></name></person-group><article-title>Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia</article-title><source>J.&#x000a0;Virol.</source><volume>88</volume><year>2014</year><fpage>4522</fpage><lpage>4532</lpage><pub-id pub-id-type="pmid">24501419</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Shirato</surname><given-names>K.</given-names></name><name><surname>Miyoshi</surname><given-names>H.</given-names></name><name><surname>Kariwa</surname><given-names>H.</given-names></name><name><surname>Takashima</surname><given-names>I.</given-names></name></person-group><article-title>Detection of West Nile virus and Japanese encephalitis virus using real-time PCR with a probe common to both viruses</article-title><source>J.&#x000a0;Virol. Methods</source><volume>126</volume><year>2005</year><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">15847927</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>T.</given-names></name><name><surname>Ni</surname><given-names>H.</given-names></name><name><surname>Beasley</surname><given-names>D.W.</given-names></name><name><surname>Ekkelenkamp</surname><given-names>M.</given-names></name><name><surname>Cardosa</surname><given-names>M.J.</given-names></name><name><surname>Barrett</surname><given-names>A.D.</given-names></name></person-group><article-title>Origin and evolution of Japanese encephalitis virus in southeast Asia</article-title><source>J.&#x000a0;Virol.</source><volume>77</volume><year>2003</year><fpage>3091</fpage><lpage>3098</lpage><pub-id pub-id-type="pmid">12584335</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Sumiyoshi</surname><given-names>H.</given-names></name><name><surname>Tignor</surname><given-names>G.H.</given-names></name><name><surname>Shope</surname><given-names>R.E.</given-names></name></person-group><article-title>Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA</article-title><source>J.&#x000a0;Infect. Dis.</source><volume>171</volume><year>1995</year><fpage>1144</fpage><lpage>1151</lpage><pub-id pub-id-type="pmid">7751689</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Nerome</surname><given-names>R.</given-names></name><name><surname>Nukui</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>F.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name></person-group><article-title>A&#x000a0;single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice</article-title><source>Virology</source><volume>396</volume><year>2010</year><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">19913862</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Nukui</surname><given-names>Y.</given-names></name><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name></person-group><article-title>Nineteen nucleotides in the variable region of 3' non-translated region are dispensable for the replication of dengue type 1 virus in vitro</article-title><source>Virus Res.</source><volume>116</volume><year>2006</year><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">16253374</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Yagasaki</surname><given-names>K.</given-names></name><name><surname>Kotaki</surname><given-names>A.</given-names></name><name><surname>Tomikawa</surname><given-names>T.</given-names></name><name><surname>Nakayama</surname><given-names>E.</given-names></name><name><surname>Moi</surname><given-names>M.L.</given-names></name><name><surname>Lim</surname><given-names>C.K.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name></person-group><article-title>In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain</article-title><source>J.&#x000a0;Gen. Virol.</source><volume>96</volume><year>2015</year><fpage>2661</fpage><lpage>2669</lpage><pub-id pub-id-type="pmid">26048886</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Takhampunya</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>H.C.</given-names></name><name><surname>Tippayachai</surname><given-names>B.</given-names></name><name><surname>Kengluecha</surname><given-names>A.</given-names></name><name><surname>Klein</surname><given-names>T.A.</given-names></name><name><surname>Lee</surname><given-names>W.J.</given-names></name><name><surname>Grieco</surname><given-names>J.</given-names></name><name><surname>Evans</surname><given-names>B.P.</given-names></name></person-group><article-title>Emergence of Japanese encephalitis virus genotype V in the Republic of Korea</article-title><source>Virol. J.</source><volume>8</volume><year>2011</year><fpage>449</fpage><pub-id pub-id-type="pmid">21943222</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>T.F.</given-names></name></person-group><article-title>New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998</article-title><source>Vaccine</source><volume>18</volume><issue>Suppl 2</issue><year>2000</year><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">10821969</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Uchil</surname><given-names>P.D.</given-names></name><name><surname>Satchidanandam</surname><given-names>V.</given-names></name></person-group><article-title>Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent</article-title><source>Am. J. Trop. Med. Hyg.</source><volume>65</volume><year>2001</year><fpage>242</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">11561712</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.P.</given-names></name><name><surname>Wu</surname><given-names>C.W.</given-names></name><name><surname>Tsao</surname><given-names>Y.P.</given-names></name><name><surname>Kuo</surname><given-names>T.W.</given-names></name><name><surname>Lou</surname><given-names>Y.C.</given-names></name><name><surname>Lin</surname><given-names>C.W.</given-names></name><name><surname>Wu</surname><given-names>S.C.</given-names></name><name><surname>Cheng</surname><given-names>J.W.</given-names></name></person-group><article-title>Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>278</volume><year>2003</year><fpage>46007</fpage><lpage>46013</lpage><pub-id pub-id-type="pmid">12952958</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.C.</given-names></name><name><surname>Lee</surname><given-names>S.C.</given-names></name></person-group><article-title>Complete nucleotide sequence and cell-line multiplication pattern of the attenuated variant CH2195LA of Japanese encephalitis virus</article-title><source>Virus Res.</source><volume>73</volume><year>2001</year><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">11163647</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name><name><surname>Nukui</surname><given-names>Y.</given-names></name><name><surname>Kotaki</surname><given-names>A.</given-names></name><name><surname>Sawabe</surname><given-names>K.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name><name><surname>Takasaki</surname><given-names>T.</given-names></name><name><surname>Tajima</surname><given-names>S.</given-names></name></person-group><article-title>Characterization of a serine-to-asparagine substitution at position 123 in the Japanese encephalitis virus E protein</article-title><source>J.&#x000a0;Gen. Virol.</source><volume>94</volume><year>2013</year><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">23052392</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="book" id="sref42"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ni</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><chapter-title>Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain</chapter-title><year>2017</year><comment>Viruses 9</comment></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name></person-group><article-title>Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities</article-title><source>Vaccine</source><volume>28</volume><year>2010</year><fpage>3635</fpage><lpage>3641</lpage><pub-id pub-id-type="pmid">20226891</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>X.Y.</given-names></name><name><surname>Liu</surname><given-names>Z.Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>X.L.</given-names></name><name><surname>Yu</surname><given-names>J.Y.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Y.P.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.J.</given-names></name><name><surname>Deng</surname><given-names>Y.Q.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>M.L.</given-names></name><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>D.Y.</given-names></name><name><surname>Li</surname><given-names>X.F.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>P.Y.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Qin</surname><given-names>C.F.</given-names></name></person-group><article-title>A&#x000a0;single mutation in the prM protein of Zika virus contributes to fetal microcephaly</article-title><source>Science</source><volume>358</volume><year>2017</year><fpage>933</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">28971967</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Date</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Miyamoto</surname><given-names>M.</given-names></name><name><surname>Yasui</surname><given-names>K.</given-names></name><name><surname>Wakita</surname><given-names>T.</given-names></name></person-group><article-title>Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone</article-title><source>J.&#x000a0;Gen. Virol.</source><volume>86</volume><year>2005</year><fpage>2209</fpage><lpage>2220</lpage><pub-id pub-id-type="pmid">16033968</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Tong</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Shan</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Tong</surname><given-names>G.</given-names></name></person-group><article-title>Acidity/alkalinity of Japanese encephalitis virus E protein residue 138 alters neurovirulence in mice</article-title><source>J.&#x000a0;Virol.</source><volume>92</volume><year>2018</year></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Chang</surname><given-names>Y.F.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>S.</given-names></name></person-group><article-title>Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells</article-title><source>Arch. Virol.</source><volume>163</volume><year>2018</year><fpage>1351</fpage><lpage>1355</lpage><pub-id pub-id-type="pmid">29411136</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0210">The following are the supplementary data related to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>Suppl. Figs.&#x000a0;191007.pptx</title></caption><media xlink:href="mmc1.pptx"><alt-text>Suppl. Figs.&#x000a0;191007.pptx</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>primer list_190703</title></caption><media xlink:href="mmc2.xlsx"><alt-text>primer list_190703</alt-text></media></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgements</title><p>We thank Kiyohiko Matsui (Nitobe Bunka College), Takuya Inagaki, and Naoko Katsuta (National Institute of Infectious Diseases) for their technical assistance.</p></ack></back></article>